Compound Evidence File
#EC-2026-0172
L-Carnitine 500mg
Filed under Injectable Oils. The bureau holds 151 laboratory returns for this compound from 53 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
53 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 8 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 10.0 | 9.9 | 10.0 | 4 Mar 2026 | 23 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 10.0 | 9.9 | 10.0 | 24 Nov 2025 | 10 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 10.0 | 9.9 | 10.0 | 27 Jan 2026 | 21 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 9.9 | 10.0 | 14 Feb 2026 | 21 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 10.0 | 10.0 | 13 Jan 2026 | 11 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 9.9 | 10.0 | 20 Mar 2026 | 10 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 3 | 10.0 | 9.9 | 10.0 | 7 Dec 2025 | 9 May 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 10.0 | 9.9 | 10.0 | 28 May 2026 | 4 Aug 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 10.0 | 9.9 | 10.0 | 18 Mar 2026 | 13 Jul 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 10.0 | 10.0 | 10.0 | 18 Apr 2026 | 26 May 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 10.0 | 10.0 | 10.0 | 20 Apr 2026 | 20 Jun 2026 |
| The Naughty NeedleCASE #VI-2026-0432 | X | 1 | 10.0 | 10.0 | 10.0 | 11 Jun 2025 | 11 Jun 2025 |
| HomopeptideCASE #VI-2026-0760 | A | 6 | 9.9 | 9.9 | 10.0 | 25 May 2026 | 25 May 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 9.9 | 9.9 | 10.0 | 28 Jan 2026 | 7 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 9.9 | 9.9 | 10.0 | 10 Jun 2026 | 5 Jul 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 9.9 | 9.9 | 10.0 | 10 Apr 2026 | 10 Jun 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 9.9 | 9.9 | 10.0 | 16 Dec 2025 | 19 May 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 9.9 | 9.9 | 10.0 | 25 Jun 2026 | 18 Aug 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 9.9 | 9.9 | 10.0 | 25 Mar 2026 | 1 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 9.9 | 9.9 | 10.0 | 24 Jan 2026 | 7 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 9.9 | 9.9 | 10.0 | 4 Feb 2026 | 12 Jun 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 9.9 | 9.9 | 10.0 | 23 Apr 2026 | 19 Aug 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 9.9 | 9.9 | 9.9 | 28 Jul 2026 | 5 Aug 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 2 | 9.5 | 9.0 | 10.0 | 23 May 2026 | 23 May 2026 |
| NextGen HealthCASE #VI-2026-0604 | X | 1 | 9.5 | 9.5 | 9.5 | 27 Feb 2025 | 27 Feb 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 5 | 8.9 | 8.2 | 9.8 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 6 | 8.6 | 6.6 | 9.7 | 21 May 2026 | 21 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 4 | 8.5 | 7.2 | 9.9 | 24 May 2026 | 24 May 2026 |
| UWA Elite PeptidesCASE #VI-2026-0130 | X | 1 | 8.1 | 8.1 | 8.1 | 3 Jul 2025 | 3 Jul 2025 |
| Yiwu Aozuo Trading CoCASE #VI-2026-0798 | X | 2 | 7.9 | 5.9 | 9.8 | 14 Jan 2025 | 26 Jan 2026 |
| Precision Peptide CoCASE #VI-2026-0559 | X | 1 | 7.9 | 7.9 | 7.9 | 2 Apr 2025 | 2 Apr 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 8 | 7.8 | 6.0 | 9.1 | 24 May 2026 | 24 May 2026 |
| Shandong Nuoweiou Medical Technology CoCASE #VI-2026-0076 | X | 1 | 7.7 | 7.7 | 7.7 | 20 Jun 2025 | 20 Jun 2025 |
| Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634 | X | 2 | 7.6 | 6.2 | 9.0 | 24 Apr 2025 | 24 May 2026 |
| Eros PeptidesCASE #VI-2026-0918 | X | 1 | 7.3 | 7.3 | 7.3 | 28 Mar 2025 | 28 Mar 2025 |
| Simple PeptideCASE #VI-2026-0782 | X | 1 | 7.2 | 7.2 | 7.2 | 8 Jul 2025 | 8 Jul 2025 |
| Allen Biotechnology Co ABCCASE #VI-2026-0709 | X | 4 | 7.0 | 4.8 | 8.7 | 20 Jun 2025 | 20 May 2026 |
| Bulk Peptide SupplyCASE #VI-2026-0446 | X | 2 | 7.0 | 5.4 | 8.5 | 3 Jun 2025 | 17 May 2026 |
| HK PeptidesCASE #VI-2026-0140 | X | 8 | 6.8 | 5.1 | 8.5 | 13 Feb 2025 | 24 May 2026 |
| Henan Sahe PeptideCASE #VI-2026-0894 | X | 1 | 6.7 | 6.7 | 6.7 | 3 Jun 2025 | 3 Jun 2025 |
| Shanghai BaojuCASE #VI-2026-0233 | X | 2 | 6.6 | 6.1 | 7.1 | 3 Jul 2025 | 21 May 2026 |
| OupeptideCASE #VI-2026-0435 | X | 3 | 6.3 | 5.9 | 6.8 | 27 Feb 2025 | 24 May 2026 |
| Elite Research USACASE #VI-2026-0267 | X | 3 | 6.0 | 5.7 | 6.7 | 16 Mar 2025 | 21 May 2026 |
| DeuschemCASE #VI-2026-0004 | X | 2 | 6.0 | 4.9 | 7.0 | 25 Apr 2025 | 23 May 2026 |
| Hunan Ruiwang Technology CenterCASE #VI-2026-0027 | X | 1 | 5.5 | 5.5 | 5.5 | 3 Jun 2025 | 3 Jun 2025 |
| ZhuoYan labCASE #VI-2026-0902 | X | 1 | 5.0 | 5.0 | 5.0 | 24 Apr 2025 | 24 Apr 2025 |
| Zen PeptidesCASE #VI-2026-0940 | X | 1 | 4.7 | 4.7 | 4.7 | 2 Apr 2025 | 2 Apr 2025 |
| Swiss ChemsCASE #VI-2026-0030 | X | 1 | 4.4 | 4.4 | 4.4 | 9 Jun 2025 | 9 Jun 2025 |
| Shenzhen Jiechuang TradingCASE #VI-2026-0292 | X | 1 | 3.4 | 3.4 | 3.4 | 13 Feb 2025 | 13 Feb 2025 |
| Dragon PharmaCASE #VI-2026-0519 | X | 1 | 3.3 | 3.3 | 3.3 | 27 Feb 2025 | 27 Feb 2025 |
| PepKitsCASE #VI-2026-0320 | X | 1 | 1.6 | 1.6 | 1.6 | 3 Jun 2025 | 3 Jun 2025 |
| Peptides For SaleCASE #VI-2026-0614 | X | 1 | 0.7 | 0.7 | 0.7 | 16 Mar 2025 | 16 Mar 2025 |
Open any subject to view the batch-level evidence for L-Carnitine 500mg alone.